Workflow
Fibrotic and Inflammatory Diseases
icon
搜索文档
Chemomab Therapeutics(CMMB) - Prospectus(update)
2023-03-23 04:45
As filed with the Securities and Exchange Commission on March 22, 2023 Registration No. 333-269218 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 4 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHEMOMAB THERAPEUTICS LTD. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Israel 2834 81-3676773 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification ...
Chemomab Therapeutics(CMMB) - Prospectus(update)
2023-02-22 19:03
As filed with the Securities and Exchange Commission on February 22, 2023 Registration No. 333-269218 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHEMOMAB THERAPEUTICS LTD. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Israel 2834 81-3676773 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identificati ...
Chemomab Therapeutics(CMMB) - Prospectus(update)
2023-02-21 19:17
As filed with the Securities and Exchange Commission on February 21, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHEMOMAB THERAPEUTICS LTD. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Israel 2834 81-3676773 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification No.) Kiryat Atidim, Build ...